Summary

Achelios Therapeutics, Inc.

Description

Achelios Therapeutics primary focus is the development of New Therapeutic Entities (NTE) for the treatment of pain and inflammation by topically delivered medications.

Strengths

  • Achelios Therapeutics, Inc. has a strong market share in their industry
  • Revenue generated per employee is greater than industry average
  • Demonstrating revenue growth that is faster than the industry average
  • The number of employees is growing faster than the industry average
  • Revenue growth is more steady than the industry average
  • Since Achelios Therapeutics, Inc. was founded, the company has grown faster than the industry average

Annual Revenue

Achelios Therapeutics, Inc.'s annual revenue

$953000

Based on Kona Equity data

  • Revenue per employee

    $158833

  • Variance of revenue growth

    0.51

  • Annual revenue growth since founding

    $79416

  • Revenue growth rate from first known quarter to current

    -77.9%

Employee Count

6 employees

  • Employee growth rate from first known quarter to current

    -76.9%

Executives

Crist Frangakis

President/Ceo

c**@achelios.com

Michael Fox

Business Chief & Commercial Officer

m**@achelios.com

John Fort

Chief Medical Officer

j**@achelios.com

Phone Therapeutics

President & Chief Executive Officer

p**@achelios.com

G Score - 6

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G2 Income per employee more than industry average.
  • G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
  • G4 Employee growth rate from the first known quarter to current is higher than the industry average.
  • G5 Variance of revenue growth is less than the industry average
  • G6 Annual revenue growth since founding is higher than the industry average.

Location

4364 S. Alston Ave., Ste. 300 
Durham, NC  27713

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

Velesco Pharmaceutical Services Inc

velescopharma.com
  • Founded in 2007
  • Location: Wixom, MI
  • Annual Revenue: $6.3M
  • Employees: 15
  • Velesco are a pharmaceutical CDMO that specializes in analytical drug development, drug formulation and GMP manufacturing. Partner with them today.

4P Therapeutics

4ptherapeutics.com
  • Founded in 2011
  • Location: Peachtree Corners, GA
  • Annual Revenue: $4.0M
  • Employees: 12
  • 4P Therapeutics is a clinical subsidiary of Nutriband Inc. (NTRB) focused on the research and development of novel drug delivery technologies and therapeutics. 4P develops products that meet the needs of patients, physicians and payers. The company has...

Aavis Pharmaceuticals Inc

aavispharmaceuticals.com
  • Founded in 2015
  • Location: Hoschton, GA
  • Annual Revenue: $4.3M
  • Employees: 19

Pharmacin

pharmacin.com
  • Location: New Haven, CT
  • Annual Revenue: $2.8M
  • Employees: 9
  • Pharmacin is a company that is dedicated to improving patient outcomes by developing best-in-class therapeutics. They use innovative technology to bring value-added medicines to the market faster and more cost-effectively. From concept to commercializa...

SciTech Development

scitechdevelopment.com
  • Founded in 2001
  • Location: Grosse Pointe, MI
  • Annual Revenue: $817.0K
  • Employees: 5
  • SciTech Development is a Specialty Pharmaceutical Company dedicated to advancing cancer treatment with a revolutionary new Drug Delivery Platform (SDP) that engineers new therapeutics for broader and better clinical outcomes. Our patented and lead drug...

Ascendia Pharmaceuticals LLC

ascendiapharma.com
  • Founded in 2012
  • Location: North Brunswick, NJ
  • Annual Revenue: $13.0M
  • Employees: 40
  • We are a specialty pharmaceutical company dedicated to developing nano-medicines for unmet medical needs with solubility and bioavailability technologies.

Key Information

  • SIC: 2834; 283
  • NAICS: 32541; 3254
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Achelios Therapeutics, Inc..

See similar companies

Frequently Asked Questions

Where is Achelios Therapeutics, Inc. located?

Achelios Therapeutics, Inc.'s headquarters are located at 4364 S. Alston Ave., Ste. 300  Durham, NC  27713.


What is Achelios Therapeutics, Inc.'s official website?

Achelios Therapeutics, Inc.'s official website is achelios.com


What is Achelios Therapeutics, Inc.'s revenue?

Achelios Therapeutics, Inc.'s annual revenue is $953.0 K.


What is Achelios Therapeutics, Inc.'s SIC code?

Achelios Therapeutics, Inc.'s SIC: 2834; 283


What is Achelios Therapeutics, Inc.'s NAICS code?

Achelios Therapeutics, Inc.'s NAICS: 32541; 3254.


How many employees does Achelios Therapeutics, Inc.'s have?

Achelios Therapeutics, Inc. has 6 employees


What industry does Achelios Therapeutics, Inc. belong to?

Achelios Therapeutics, Inc. is in the industry of Biotechnology.

Next step

Visitors review